Aeternum C2, a native C++ botnet loader, operates on smart contracts on the Polygon blockchain, increasing its resilience.

The module targets Claude Code, Claude Desktop, Cursor, Microsoft Visual Studio Code (VS Code) Continue, and Windsurf. It also harvests API keys for nine large language models (LLM) providers: ...

The American Petroleum Institute is moving closer to finalizing its Proposed Category 12 (PC-12) heavy-duty engine oil specification, marking a key step toward two new oil categories, API CL-4 and API ...

The game picks up as Dylan’s former captors, the Federal Bureau of Control (FBC), are deploying him at the peak of a supernatural crisis to combat a mysterious cosmic entity. Per the official logline, ...

Microsoft has disclosed details of a novel backdoor dubbed SesameOp that uses OpenAI Assistants Application Programming Interface (API) for command-and-control (C2) communications. "Instead of relying ...

Microsoft Incident Response – Detection and Response Team (DART) researchers uncovered a new backdoor that is notable for its novel use of the OpenAI Assistants Application Programming Interface (API) ...

CEO Russell Becker highlighted a record third quarter, stating "the business continues to have strong momentum, delivering robust top line growth while expanding margins." Becker described investments ...

Drugmaker AbbVie plans to construct a $195 million facility near its headquarters in North Chicago to manufacture active pharmaceutical ingredients, The Chicago Tribune reported Aug. 12. Construction ...

APi Group increased full year 2025 net revenue guidance to "$7.65 billion to $7.85 billion, up from $7.4 billion to $7.6 billion, representing organic growth in net revenues of 4% to 7% for the year." ...

Emzor Pharmaceutical Industries Limited, a leading pharmaceutical company in Nigeria, has announced a ground-breaking $230 million investment in a new Active Pharmaceutical Ingredients (API) ...

Roughly a year after receiving an FDA reprimand at its manufacturing plant in Michigan, Indian drugmaker Piramal Pharma has landed in the regulator’s crosshairs once again. Following an inspection of ...